Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide

Cancer Research

Volumn 61, Issue 1, 2001, Pages 376-382

  Jurasz, Paul ^a   Sawicki, Grzegorz ^a   Duszyk, Marek ^a   Sawicka, Jolanta ^a   Miranda, Carlos ^a   Mayers, Irvin ^a   Radomski, Marek W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; NITRIC OXIDE;

ARTICLE; CANCER CELL CULTURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FIBROSARCOMA; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CELL COMMUNICATION; ENZYME INHIBITORS; EPOPROSTENOL; FIBROSARCOMA; GELATINASES; GLUTATHIONE; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OXADIAZOLES; PENICILLAMINE; PEPTIDES, CYCLIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; QUINOXALINES; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOGLUTATHIONE; THROMBOXANE A2; TUMOR CELLS, CULTURED;

EID: 0035134519     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Antimetastatic effects associated with platelet reduction
2. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease
3. Regulation of natural killer cell function by nonlymphoid cells
4. Protection from tumor necrosis factor-mediated cytolysis by platelets
5. Pulmonary microembolism
6. Potential role of platelets in the pathogenesis of tumor metastasis
7. Platelets and cancer metastasis: More than an epiphenomenon
8. Platelet number and interleukin-6 correlate with VEGF but not with bFGF levels of advanced cancer patients
9. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
10. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas
11. Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition of studies with apyrase, hirudin, and phospholipase
12. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide
13. The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation
14. 3in tumor-cell induced platelet aggregation
15. Characterization of tumor-induced platelet aggregation: The role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells
16. Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-Ibα with different functional properties
17. Release of gelatinase A during platelet activation mediates aggregation
18. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
19. Tumor invasion and metastases-role of the extracellular matrix: Rhoad's Memorial Award Lecture
20. The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis
21. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets
22. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide
23. Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets
24. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
25. An improved method for washing platelets with prostacyclin
26. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart
27. Localization and translocation of MMP-2 during aggregation of human platelets
28. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
29. The solution confirmation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibinogen receptor antagonist
30. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines
31. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
32. Prostacyclin: A potent antimetastatic agent
33. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2
34. 3
35. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor
36. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells
37. Endothelin-1 tumour development
38. Raised endothelin 1 levels in patients with colorectal liver metastases
39. Paracrine regulation of ovarian cancer by endothelin
40. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
41. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
42. Nitric oxide: An endogenous modulator of leukocyte adhesion
43. Inactivation of ribonucleotide reductase by nitric oxide
44. Vascular biosynthesis of nitric oxide: Effect on hemostasis and fibrinolysis
45. Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis
46. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53
47. Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines
48. Roles of nitric oxide in tumor growth
49. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway
50. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate cf in vivo nitric oxide in patients with gastric cancer
51. Nitric oxide synthase inhibition by N(G)-nitro-Larginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
52. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients
53. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells
54. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade
55. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma
56. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-α-induced apoptosis in MCF-7 and other epithelial tumor cells
57. Therapy of human ovarian cancer by transfection with the murine interferon β gene: Role of macrophage-inducible nitric oxide synthase
58. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
59. Targeting nitric oxide to cancer cells: Cytotoxicity studies of glyco-S-nitrosothiols
60. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma
61. Endothelium, coronary vasodilation, and organic nitrates
62. Effects of S-nitrosoglutathione in the human forearm circulation. Evidence for selective inhibition of platelet activation
63. Evidence for a cyclic GMP-independent mechanism in the antiplatelet action of S-nitroso-glutathione